A Rare Type of Hodgkin's Disease

Publisher Website
Google Scholar
Abstract
The interest in Hodgkin's disease in recent years has resulted in improved understanding and treatment of the disease. Among the advances have been a greater attention and ability to detect the extent of the disease, substantial improvement in delivering radiotherapy and parallel advances in the use of chemotherapeutic drugs. The contribution of Lukes, Butler and Hicks1 7 years ago in recognizing the clinicopathological entity of nodular sclerosis was most important in enhancing our understanding of the variables in the clinical picture of this fascinating disease. In this issue of the Journal, Lukes and his colleagues have provided another clear . . .

This publication has 3 references indexed in Scilit: